LIMN
Liminatus Pharma, Inc. - Class A Common Stock (LIMN)
$13
About Liminatus Pharma, Inc. - Class A Common Stock (LIMN)
Liminatus Pharma, Inc. is a pre-clinical stage biopharmaceutical company, which engages in developing novel, immune-modulating cancer therapies. The company was founded on November 1, 2020 and is headquartered in Cerritos, CA.
Details
Daily high
$0.14
Daily low
$0.13
Price at open
$0.13
52 Week High
$4.06
52 Week Low
$0.10
Market cap
9.5M
Dividend yield
-
Volume
3.9M
Avg. volume
32.5M
P/E ratio
-.33
Liminatus Pharma, Inc. - Class A Common Stock News
Details
Daily high
$0.14
Daily low
$0.13
Price at open
$0.13
52 Week High
$4.06
52 Week Low
$0.10
Market cap
9.5M
Dividend yield
-
Volume
3.9M
Avg. volume
32.5M
P/E ratio
-.33